Status:
RECRUITING
Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy
Lead Sponsor:
Gaziosmanpasa Research and Education Hospital
Conditions:
Cerebral Palsy Spastic Diplegia
Eligibility:
All Genders
4-12 years
Phase:
PHASE4
Brief Summary
The aim of this study is to investigate the effects of Botulinum Neurotoxin-A (BoNT-A) injection applied to spastic muscles on pain sensation and Selective Motor Control (SMC) in cases diagnosed with ...
Detailed Description
Cerebral Palsy (CP) is a non-progressive, permanent neurological disorder that occurs in the fetal or infant brain. CP, defined as a group of non-progressive movement and posture disorders, is the mos...
Eligibility Criteria
Inclusion
- Patients diagnosed with Cerebral Palsy
- Between the ages of 4-12
- GMFCS (Gross Motor Function Classification System)1-4
- Patients who have received an appropriate indication for BoNT-A injection from an experienced physiatrist
- Patients who have not had botulinum toxin administered in the last 6 months
Exclusion
- Mental retardation
- GMFCS 5
- Have an intrathecal baclofen pump for spasticity treatment or history of soft tissue and/or bone surgery
- Underwent dorsal rhizotomy
- Have an active infection or a localized skin infection at the injection site
- Using aminoglycoside antibiotics
- Contracture
Key Trial Info
Start Date :
September 3 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 5 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06583343
Start Date
September 3 2024
End Date
May 5 2025
Last Update
May 7 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziosmanpasa Research and Education Hospital
Istanbul, Gaziosmanpaşa, Turkey (Türkiye), 34255